[3,4-diaminopyridine in the treatment of myasthenic syndromes. Practical aspects].
Vílchez
J J
JJ
Casanova
B
B
Monte
E
E
D015761:4-Aminopyridine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077770:Amifampridine; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000188:drug therapy*; D009157:Myasthenia Gravis / Q000188:drug therapy*; D015221:Potassium Channels; D013997:Time Factors
D015221:Potassium Channels; D015761:4-Aminopyridine; D000077770:Amifampridine
3,4-diaminopiridina en el tratamiento de síndromes miasténicos. Aspectos prácticos.